Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
24.07
+0.35 (1.48%)
Oct 8, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Millions GBX. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Buprenorphine-based Prescription Drugs
879.29M
Log In
Log In
Log In
Log In
Upgrade
Buprenorphine-based Prescription Drugs Growth
20.21%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions GBX. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
733.68M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
23.63%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
141.59M
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
6.34%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
4.02M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
-17.42%
Log In
Log In
Log In
Log In
Upgrade